Patient assistance program (PAP)

What is Patient assistance program (PAP)?

A manufacturer program giving free medication to qualifying low-income patients.

Novo Nordisk's covers the Ozempic pen for uninsured people at or below 200% of the federal poverty level, but not Wegovy; Lilly Cares covers Trulicity but not Mounjaro or Zepbound (checked October 2026). Enrollment is renewed yearly.

GLP Watchdog writes these definitions from FDA labels and peer-reviewed PubMed literature.

Where Patient assistance program (PAP) comes up on this site

On GLP Watchdog, Patient assistance program comes up in 1 research article.

Other terms under insurance

• PBM (Pharmacy Benefit Manager)
• Copay accumulator
• Specialty pharmacy
• Mail-order pharmacy
• Quantity limit
• Bridge therapy
• Manufacturer coupon
• Deductible
• Coinsurance

Where the evidence lives

• The full GLP-1 glossary (149 terms, 8 categories)
• Research articles — written from primary sources
• Tools and calculators
• Compare GLP-1 telehealth providers